Chemoinformaics analysis of GYMNEMASIN-D
Molecular Weight | 666.849 | nRot | 5 |
Heavy Atom Molecular Weight | 608.385 | nRig | 33 |
Exact Molecular Weight | 666.398 | nRing | 6 |
Solubility: LogS | -3.716 | nHRing | 1 |
Solubility: LogP | 2.201 | No. of Aliphatic Rings | 6 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 105 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 47 | No. of Aromatic Carbocycles | 0 |
nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 58 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 36 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 11 | No. of Arom Bond | 0 |
nHA | 10 | APOL | 107.616 |
nHD | 8 | BPOL | 62.526 |
QED | 0.158 |
Synth | 5.627 |
Natural Product Likeliness | 2.88 |
NR-PPAR-gamma | 0.897 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0.005 |
HIA | 0.927 |
CACO-2 | -5.745 |
MDCK | 0.000142361 |
BBB | 0.304 |
PPB | 0.825404 |
VDSS | 0.636 |
FU | 0.169895 |
CYP1A2-inh | 0 |
CYP1A2-sub | 0.104 |
CYP2c19-inh | 0 |
CYP2c19-sub | 0.621 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.095 |
CYP2d6-inh | 0 |
CYP2d6-sub | 0.13 |
CYP3a4-inh | 0.033 |
CYP3a4-sub | 0.023 |
CL | 0.997 |
T12 | 0.09 |
hERG | 0.011 |
Ames | 0.039 |
ROA | 0.111 |
SkinSen | 0.004 |
Carcinogencity | 0.029 |
EI | 0.004 |
Respiratory | 0.812 |
NR-Aromatase | 0.888 |
Antiviral | Yes |
Prediction | 0.831969 |